收藏切换
Advanced research and technology development of antibody-drug conjugates
收藏切换
PDF
Hong-bin SONG*, Dong-lian LIU, Peng-fei LI, Ji-dong ZHAO, Yan-fei QU
Acta Pharmaceutica Sinica | 2019, 54(10) : 1810 - 1817
Less
收藏切换
Acta Pharmaceutica Sinica | 2019, 54(10): 1810-1817
Reviews
Advanced research and technology development of antibody-drug conjugates
Full
Hong-bin SONG*, Dong-lian LIU, Peng-fei LI, Ji-dong ZHAO, Yan-fei QU
Affiliations
  • TOT Biopharm, Suzhou 215123, China
Published: 2019-10-12 doi: 10.16438/j.0513-4870.2019-0563
Outline
收藏切换

Although numbers of naked antibodies showing clinical efficacy as single agents, their therapeutic effect is limited. Chemotherapy is very effective but with relatively large side effects, so conjugation of small chemotherapeutic drugs to antibodies is one of the important methods to enhance therapeutic potential of antibodies. Antibody-drug conjugates (ADCs) represent a promising therapeutic approach for cancer patients by combining the antigen-targeting specificity of monoclonal antibodies (mAbs) with the cytotoxic potency of chemotherapeutic drugs. These modified antibodies are expected to selectively deliver chemotherapeutic drugs to tumor cells and provide sustained clinical benefit to cancer patients, at the same time, minimizing systemic toxicity. ADCs are expected to bring together the benefits of highly potent drugs on the one hand and selective binders of specific tumor antigens on the other hand. However, designing an ADC is very complex, requiring thoughtful combination of antibody, linker, and payload drugs in the context of a target and a defined cancer indication. Although many challenges remain, recent clinical success has generated intense interest in this therapeutic class.

antibody-drug conjugate  /  cytotoxic compound  /  linker  /  payload
Hong-bin SONG, Dong-lian LIU, Peng-fei LI, Ji-dong ZHAO, Yan-fei QU. Advanced research and technology development of antibody-drug conjugates[J]. Acta Pharmaceutica Sinica, 2019 , 54 (10) : 1810 -1817 . DOI: 10.16438/j.0513-4870.2019-0563
Year 2019 volume 54 Issue 10
PDF
180
67
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2019-0563
  • Receive Date:2019-07-16
  • Online Date:2026-01-26
  • Published:2019-10-12
Article Data
Affiliations
History
  • Received:2019-07-16
  • Revised:2019-09-05
Affiliations
    TOT Biopharm, Suzhou 215123, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2019-0563
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT